Common Contracts

SHARED CARE AGREEMENT

Shared Care Agreement • February 11th, 2020

• Contract Type
  Shared Care Agreement
• Filed
  February 11th, 2020

CATEGORY: Guidelines CLASSIFICATION: Clinical PURPOSE This shared care agreement outlines the responsibilities for managing the prescribing and administration of Denosumab (Prolia®) for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures and how they are to be shared between the secondary care specialist (University Hospital Birmingham NHS Foundation Trust [UHB]) and primary care physician (GP)/primary care prescriber. Controlled Document Number: CG817 Version Number: 1 Controlled Document Sponsor: Service Lead, Endocrinology Controlled Document Lead:  Sherwin Criseno- Lead CNS, Endocrinology Prof. Neil Gittoes- Consultant, Endocrinology Approved By: On: June 2017 Review Date: June 2020 Distribution: Essential Reading for: Information for: All clinical staff dealing with postmenopausal women and men at risk of osteoporosis.All other clinical staff.